UNSPSC 85445904: The diagnosis of benzothiadiazine derivatives

In this classification, this covers the group of activities that yields a diagnosis of benzothiadiazine derivatives. Benzothiadiazine derivatives is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y54.3.

UNSPSC 85445904 Diagnosis of benzothiadiazine derivatives is a Commodity code that shows a fundamental mismatch between its nominal scope and recent state and local procurement activity. The three opportunities posted under this code between July and October 2026 involve diagnostic imaging systems, special education contracted services, and temporary health professional staffing — none of which relate to the diagnosis or clinical use of benzothiadiazine derivatives or their chemical characterization. The code shows little relevant recent activity aligned with its stated purpose.

The opportunities that do appear under this code reflect core state and local health and education service delivery: San Mateo Medical Center (a county public hospital system) is procuring an enterprise-grade Picture Archiving and Communication System (PACS) for radiology, cardiology, and dental imaging with EPIC integration, due October 21, 2026; Birdville Independent School District in northeast Tarrant County, Texas, is soliciting temporary special education contracted services (audiologists, diagnosticians, therapists, and other specialists) across 30 campuses, due October 21, 2026; and Santa Clara County Health System is establishing a qualified vendor pool for temporary ancillary clinical staffing across 13 health professional categories including diagnostic imaging and cardiology, due October 7, 2026. The issuing bodies span county hospital systems and school districts in California and Texas. Given the code's technical definition and the absence of pharmaceutical-diagnosis or chemical-testing opportunities in the recent record, this code does not represent a viable pursuit category for pharmaceutical or clinical laboratory vendors focused on benzothiadiazine diagnostic applications.